These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31954399)

  • 21. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
    Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC
    PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
    Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of influence of the glutamatergic concentration of [
    Dupont AC; Serrière S; Barantin L; Vercouillie J; Tauber C; Gissot V; Bodard S; Chicheri G; Chalon S; Bonnet-Brilhault PF; Santiago-Ribeiro PM; Arlicot N
    Transl Psychiatry; 2021 Jan; 11(1):66. PubMed ID: 33473111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [(18)F]FPEB and [(18)F]FDEGPECO comparative study of mGlu5 quantification in rodent brain.
    Kang JH; Lee M; Ryu YH; Lyoo CH; Kim CH; Lee KC; Choi TH; Choi JY
    Appl Radiat Isot; 2015 Apr; 98():103-7. PubMed ID: 25658029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer.
    Lee M; Lee HJ; Park IS; Park JA; Kwon YJ; Ryu YH; Kim CH; Kang JH; Hyun IY; Lee KC; Choi JY
    Neuropharmacology; 2018 May; 133():512-517. PubMed ID: 29427650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients.
    Müller Herde A; Schibli R; Weber M; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):407-420. PubMed ID: 30291374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy.
    Lam J; DuBois JM; Rowley J; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Rosa-Neto P; Kobayashi E
    Ann Neurol; 2019 Feb; 85(2):218-228. PubMed ID: 30597619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Characterization of mGluR5 Using
    Bertoglio D; Kosten L; Verhaeghe J; Thomae D; Wyffels L; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
    J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
    Leuzy A; Zimmer ER; Dubois J; Pruessner J; Cooperman C; Soucy JP; Kostikov A; Schirmaccher E; Désautels R; Gauthier S; Rosa-Neto P
    Brain Struct Funct; 2016 Apr; 221(3):1387-402. PubMed ID: 25596865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examining sex differences in responses to footshock stress and the role of the metabotropic glutamate receptor 5: an [
    Asch RH; Pothula S; Toyonaga T; Fowles K; Groman SM; Garcia-Milian R; DiLeone RJ; Taylor JR; Esterlis I
    Neuropsychopharmacology; 2023 Feb; 48(3):489-497. PubMed ID: 36100654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [
    DeLorenzo C; Gallezot JD; Gardus J; Yang J; Planeta B; Nabulsi N; Ogden RT; Labaree DC; Huang YH; Mann JJ; Gasparini F; Lin X; Javitch JA; Parsey RV; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2716-2727. PubMed ID: 27742888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.